China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class ASZSE: 000999

China Resources Sanjiu Medical & Pharmaceutical Co: Revenue up 18.62% but net profit down 15.29% as costs and investments surged

· Issued by China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class A

Q1 2026 revenue grew 18.62% year-over-year, but net profit fell 15.29% due to sharply higher sales and R&D expenses. Operating cash flow improved, while cash reserves declined as debt repayments increased and government subsidies dropped.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Company analysis

Earlier from China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class A

All China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class A news releases